{"product_id":"drug-induced-movement-disorders-isbn-9781405126199","title":"Drug Induced Movement Disorders","description":"The second revised edition of this text will update and present current state of the art clinical approaches to this subject. This book will continue to be the source text of information on drug-induced movement disorders authored and edited by the pioneers in the field. It will be an invaluable addition to the library of any neurologist.  \u003cb\u003eSection 1: General Considerations\u003c\/b\u003e. \u003cp\u003eChapter 1: Movement Disorders: Approach, Definitions and differential Diagnosis.\u003c\/p\u003e \u003cp\u003e\u003ci\u003eMartin Cloutier, Anthony E. Lang\u003c\/i\u003e.\u003c\/p\u003e \u003cp\u003eChapter 2: Rating Scales for Movement Disorders.\u003c\/p\u003e \u003cp\u003e\u003ci\u003eWonodi I, Hong EH, Avila MT, Gunvant Thaker\u003c\/i\u003e.\u003c\/p\u003e \u003cp\u003eChapter 3: Spontaneous movement disorders in psychiatric patients.\u003c\/p\u003e \u003cp\u003e\u003ci\u003eIrene Richard, Christopher O’Brien, Roger Kurlan\u003c\/i\u003e.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 2: Antipsychotics\u003c\/b\u003e.\u003c\/p\u003e \u003cp\u003eChapter 4: Pharmacology of typical and atypical agents.\u003c\/p\u003e \u003cp\u003e\u003ci\u003eGary Remington, Shitij Kapur\u003c\/i\u003e.\u003c\/p\u003e \u003cp\u003eChapter 5: Acute Drug-induced Dystonia.\u003c\/p\u003e \u003cp\u003e\u003ci\u003eMichael F. Mazurek, Patricia I. Rosebush\u003c\/i\u003e.\u003c\/p\u003e \u003cp\u003eChapter 6: Drug-Induced Parkinsonism.\u003c\/p\u003e \u003cp\u003e\u003ci\u003eJoseph H. Friedman, Martha E. Trieschmann, Hubert H. Fernandez\u003c\/i\u003e.\u003c\/p\u003e \u003cp\u003eChapter 7: Acute Akathisia.\u003c\/p\u003e \u003cp\u003eAuthor: Lenard A. Adler, John Rotrosen, Burt Angrist.\u003c\/p\u003e \u003cp\u003eChapter 8: Neuroleptic Malignant Syndrome.\u003c\/p\u003e \u003cp\u003e\u003ci\u003eStewart A. Factor\u003c\/i\u003e.\u003c\/p\u003e \u003cp\u003eChapter 9: Classical Tardive Dyskinesia.\u003c\/p\u003e \u003cp\u003e\u003ci\u003eThomas M. Hyde, MD, Jose A. Apud, Whitney C. Fisher, Michael F. Egan.\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eChapter 10: Tardive dyskinesia Variants.\u003c\/p\u003e \u003cp\u003e\u003ci\u003eSkidmore F, Weiner W, Burke R.\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eChapter 11: Movement Disorders caused by atypical antipsychotics.\u003c\/p\u003e \u003cp\u003e\u003ci\u003eKaren E. Anderson\u003c\/i\u003e.\u003c\/p\u003e \u003cp\u003eChapter 12: Commentary: Is Tardive dyskinesia disappearing?\u003ci\u003eJames Lohr, MD\u003c\/i\u003e.\u003c\/p\u003e \u003cp\u003e.\u003c\/p\u003e \u003cp\u003e.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 3: Dopaminomimetic Drugs\u003c\/b\u003e.\u003c\/p\u003e \u003cp\u003eChapter 13: Dyskinesia induced by levodopa and dopamine agonists in Parkinson’s disease.\u003c\/p\u003e \u003cp\u003e\u003ci\u003eJohn G. Nutt, Matthew Brodsky\u003c\/i\u003e.\u003c\/p\u003e \u003cp\u003eChapter 14: Stimulant Drugs.\u003c\/p\u003e \u003cp\u003e\u003ci\u003eAnthony E. Munson, Juan Sanchez-Ramos, William J Weiner\u003c\/i\u003e.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 5: Other Drugs\u003c\/b\u003e.\u003c\/p\u003e \u003cp\u003eChapter 15: Antidepressants.\u003c\/p\u003e \u003cp\u003e\u003ci\u003eMarie L. Moro-de-Casillas, David E. Riley\u003c\/i\u003e.\u003c\/p\u003e \u003cp\u003eChapter 16: Anticonvulsants.\u003c\/p\u003e \u003cp\u003e\u003ci\u003eJohn C. Morgan, Madeline Harrison\u003c\/i\u003e.\u003c\/p\u003e \u003cp\u003eChapter 17: Miscellaneous Drugs.\u003c\/p\u003e \u003cp\u003e\u003ci\u003eDaniel Tarsy\u003c\/i\u003e\u003c\/p\u003e  \"This well written comprehensive book provides the reader with good clinical descriptions of the major movement disorders and with extensively referenced data on studies and trials regarding both drugs incriminated in abnormal movements and those useful in their management.\"\u003cbr\u003e \u003cp\u003e\u003cbr\u003e \u003c\/p\u003e \u003cp\u003e\"In conclusion, this comprehensive review of drug-induced movement disorders will be extremely useful to every clinician, particularly those interested in the fields of neurology and psychiatry.\"\u003cbr\u003e \u003c\/p\u003e \u003cp\u003e\u003cbr\u003e \u003c\/p\u003e \u003cp\u003e\u003cb\u003eChristian Wider, European Neurology, December 5th 2005\u003c\/b\u003e\u003c\/p\u003e  Dr. Stewart Factor, DO. Professor of Neurology, Riley Family Chair in Parkinson's Disease, Director, Parkinson's Disease and Movement Disorder Program, Albany Medical Center \u003cp\u003eDr. Anthony E. Lang, MD. Movement Disorder Clinic, Toronto Western Hospital\u003c\/p\u003e \u003cp\u003eDr. William J. Weiner, MD. Chair, Department of Neurology, University of Maryland School of Medicine\u003c\/p\u003e The second revised edition of this text will update and present current state of the art clinical approaches to this subject. This book will continue to be the source text of information on drug-induced movement disorders authored and edited by the pioneers in the field. It will be an invaluable addition to the library of any neurologist.","brand":"Wiley-Blackwell","offers":[{"title":"Default Title","offer_id":47989088321765,"sku":"NP9781405126199","price":256.95,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9781405126199.jpg?v=1761782746","url":"https:\/\/k12savings.com\/products\/drug-induced-movement-disorders-isbn-9781405126199","provider":"K12savings","version":"1.0","type":"link"}